364 related articles for article (PubMed ID: 32860695)
1. Gut Microbiota and Oral Contraceptive Use in Overweight and Obese Patients with Polycystic Ovary Syndrome.
Eyupoglu ND; Ergunay K; Acikgoz A; Akyon Y; Yilmaz E; Yildiz BO
J Clin Endocrinol Metab; 2020 Dec; 105(12):. PubMed ID: 32860695
[TBL] [Abstract][Full Text] [Related]
2. Circulating gut microbiota metabolite trimethylamine N-oxide and oral contraceptive use in polycystic ovary syndrome.
Eyupoglu ND; Caliskan Guzelce E; Acikgoz A; Uyanik E; Bjørndal B; Berge RK; Svardal A; Yildiz BO
Clin Endocrinol (Oxf); 2019 Dec; 91(6):810-815. PubMed ID: 31556132
[TBL] [Abstract][Full Text] [Related]
3. Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota.
Jobira B; Frank DN; Pyle L; Silveira LJ; Kelsey MM; Garcia-Reyes Y; Robertson CE; Ir D; Nadeau KJ; Cree-Green M
J Clin Endocrinol Metab; 2020 Jun; 105(6):e2134-44. PubMed ID: 31970418
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota alterations reveal potential gut-brain axis changes in polycystic ovary syndrome.
Liang Z; Di N; Li L; Yang D
J Endocrinol Invest; 2021 Aug; 44(8):1727-1737. PubMed ID: 33387350
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota in adolescent girls with polycystic ovary syndrome: Effects of randomized treatments.
Garcia-Beltran C; Malpique R; Carbonetto B; González-Torres P; Henares D; Brotons P; Muñoz-Almagro C; López-Bermejo A; de Zegher F; Ibáñez L
Pediatr Obes; 2021 Apr; 16(4):e12734. PubMed ID: 32989872
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report.
Liang Y; Ming Q; Liang J; Zhang Y; Zhang H; Shen T
Can J Physiol Pharmacol; 2020 Nov; 98(11):803-809. PubMed ID: 32150694
[TBL] [Abstract][Full Text] [Related]
7. Characterization of gut microbiota in polycystic ovary syndrome: Findings from a lean population.
Mammadova G; Ozkul C; Yilmaz Isikhan S; Acikgoz A; Yildiz BO
Eur J Clin Invest; 2021 Apr; 51(4):e13417. PubMed ID: 32991745
[TBL] [Abstract][Full Text] [Related]
8. Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity.
Insenser M; Murri M; Del Campo R; Martínez-García MÁ; Fernández-Durán E; Escobar-Morreale HF
J Clin Endocrinol Metab; 2018 Jul; 103(7):2552-2562. PubMed ID: 29897462
[TBL] [Abstract][Full Text] [Related]
9. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
10. Hepatic steatosis relates to gastrointestinal microbiota changes in obese girls with polycystic ovary syndrome.
Jobira B; Frank DN; Silveira LJ; Pyle L; Kelsey MM; Garcia-Reyes Y; Robertson CE; Ir D; Nadeau KJ; Cree-Green M
PLoS One; 2021; 16(1):e0245219. PubMed ID: 33465100
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-22/Interleukin-22 binding protein axis and oral contraceptive use in polycystic ovary syndrome.
Aksun S; Ersal E; Portakal O; Yildiz BO
Endocrine; 2023 Jul; 81(1):54-57. PubMed ID: 37012532
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the gut microbiota in polycystic ovary syndrome with dyslipidemia.
Yang T; Li G; Xu Y; He X; Song B; Cao Y
BMC Microbiol; 2024 May; 24(1):169. PubMed ID: 38760705
[TBL] [Abstract][Full Text] [Related]
13. Perturbations in gut microbiota composition in patients with polycystic ovary syndrome: a systematic review and meta-analysis.
Li P; Shuai P; Shen S; Zheng H; Sun P; Zhang R; Lan S; Lan Z; Jayawardana T; Yang Y; Zhao J; Liu Y; Chen X; El-Omar EM; Wan Z
BMC Med; 2023 Aug; 21(1):302. PubMed ID: 37559119
[TBL] [Abstract][Full Text] [Related]
14. Blood Bacterial 16S rRNA Gene Alterations in Women With Polycystic Ovary Syndrome.
Wang Q; Wang Q; Zhao L; Bin Y; Wang L; Wang L; Zhang K; Li Q
Front Endocrinol (Lausanne); 2022; 13():814520. PubMed ID: 35282443
[TBL] [Abstract][Full Text] [Related]
15. Pituitary function is altered during the same cycle in women with polycystic ovary syndrome treated with continuous or cyclic oral contraceptives or a gonadotropin-releasing hormone agonist.
Ruchhoft EA; Elkind-Hirsch KE; Malinak R
Fertil Steril; 1996 Jul; 66(1):54-60. PubMed ID: 8752611
[TBL] [Abstract][Full Text] [Related]
16. Combined Oral Contraceptive Treatment Does Not Alter the Gut Microbiome but Affects Amino Acid Metabolism in Sera of Obese Girls With Polycystic Ovary Syndrome.
Tayachew B; Vanden Brink H; Garcia-Reyes Y; Rahat H; D'Alessandro A; Frank DN; Robertson CE; Silveira L; Kelsey M; Pyle L; Cree-Green M
Front Physiol; 2022; 13():887077. PubMed ID: 35800349
[No Abstract] [Full Text] [Related]
17. Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome.
Li N; Li Y; Qian C; Liu Q; Cao W; Ma M; He R; Chen R; Geng R; Liu Y
Front Cell Infect Microbiol; 2020; 10():624504. PubMed ID: 33665172
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study.
Kyrkou G; Trakakis E; Attilakos A; Panagopoulos P; Chrelias C; Papadimitriou A; Vaggopoulos V; Alexiou E; Mastorakos G; Lykeridou A; Kassanos D; Papaevangelou V; Papantoniou N
Arch Gynecol Obstet; 2016 Apr; 293(4):915-23. PubMed ID: 26615602
[TBL] [Abstract][Full Text] [Related]
19. The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits.
Lüll K; Arffman RK; Sola-Leyva A; Molina NM; Aasmets O; Herzig KH; Plaza-Díaz J; Franks S; Morin-Papunen L; Tapanainen JS; Salumets A; Altmäe S; Piltonen TT; Org E
J Clin Endocrinol Metab; 2021 Mar; 106(3):858-871. PubMed ID: 33205157
[TBL] [Abstract][Full Text] [Related]
20. The gut microbial composition in polycystic ovary syndrome with insulin resistance: findings from a normal-weight population.
He F; Li Y
J Ovarian Res; 2021 Mar; 14(1):50. PubMed ID: 33773586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
